General News

COVID-19: FDA approves first herbal medicine for clinical trial

The Ghana Food and Drugs Authority (FDA) in collaboration with the National Medicine Regulatory Agency (NMRA) has approved a herbal medicine ‘Cryptolepis Sanguinolenta’ locally known as Nibima for clinical trials for the treatment of Covid-19.

In a press statement, the CEO of FDA indicated that the approval of the herbal medicine comes on the back of laboratory studies conducted by the Kwame Nkrumah University of Science and Technology (KNUST) research team which proves the efficacy of the medicine against the novel coronavirus.

fda nimina 500x500 - COVID-19: FDA approves first herbal medicine for clinical trial
Cryptolepis sanguinolenta (nibima)

See Press Release below;

Thank you for visiting FTHGhana.com for your Technology, Travel and Housing News. Share this to all across and follow us on; Facebook Twitter

Leave a Reply

Back to top button
error: